Literature DB >> 427006

Quinidine dosage, with special reference to an oral loading dose schedule.

P Collste, R Nordlander.   

Abstract

1 Plasma concentrations of quinidine were analyzed in 52 cardiac patients after different oral loading doses and during different maintenance dosage intervals using both conventional and sustained release preparations of quinidine. 2 The majority of patients reached therapeutic plasma concentrations in the order of 2--4 microgram/ml within 3 h after the loading dose of 600--800 mg of rapidly absorbed ordinary quinidine sulphate tablets and institution of maintenance therapy with sustained release tablets 1 h after the loading dose. 3 The dosage interval of 12 h during maintenance therapy with sustained release tablets gave as acceptable plasma drug fluctuations as an 8 h interval. 4 A large individual variation in plasma concentrations was noticed. Thus monitoring of therapy by plasma concentration analyses is desirable.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 427006      PMCID: PMC1429490          DOI: 10.1111/j.1365-2125.1979.tb00935.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  21 in total

1.  QUANTITATIVE DETERMINATION OF QUINIDINE IN PLASMA.

Authors:  G CRAMER; B ISAKSSON
Journal:  Scand J Clin Lab Invest       Date:  1963       Impact factor: 1.713

2.  SOME CELLULAR AND METABOLIC CONSIDERATIONS RELATING TO THE ACTION OF QUINIDINE AS A PROTOTYPE ANTIARRHYTHMIC AGENT.

Authors:  H L CONN; R J LUCHI
Journal:  Am J Med       Date:  1964-11       Impact factor: 4.965

3.  A new quinidine preparation with sustained release.

Authors:  G CRAMER; E VARNAUSKAS; L WERKO
Journal:  Acta Med Scand       Date:  1963-04

4.  Factors influencing conversion of chronic atrial fibrillation with special reference to serum quinidine concentration.

Authors:  R E BALL; M SOKOLOW
Journal:  Circulation       Date:  1956-10       Impact factor: 29.690

5.  Serum quinidine concentration in congestive heart failure.

Authors:  M G BROWN; D HOLZMAN; E W CREELMAN
Journal:  Am J Med Sci       Date:  1953-02       Impact factor: 2.378

6.  Comparison of quinidine plasma concentration curves following oral administration of some short- and long-acting formulations.

Authors:  G M Frigo; E Perucca; M Teggia-Droghi; G Gatti; A Mussini; J Salerno
Journal:  Br J Clin Pharmacol       Date:  1977-08       Impact factor: 4.335

7.  Serum quinidine levels after administration of three different quinidine preparations.

Authors:  R Henning; G Nyberg
Journal:  Eur J Clin Pharmacol       Date:  1973-12       Impact factor: 2.953

8.  Relation between serum quinidine levels and renal function. Studies in normal subjects and patients with congestive failure and renal insufficiency.

Authors:  S Bellet; L R Roman; A Boza
Journal:  Am J Cardiol       Date:  1971-04       Impact factor: 2.778

9.  Pharmacokinetic studies of quinidine in patients with arrhythmias.

Authors:  K A Conrad; B L Molk; C A Chidsey
Journal:  Circulation       Date:  1977-01       Impact factor: 29.690

10.  THE RELATIONSHIP OF DOSAGE SCHEDULE TO THE BLOOD LEVEL OF QUINIDINE, USING ALL AVAILABLE QUINIDINE PREPARATIONS.

Authors:  W M GOLDBERG; S G CHAKRABARTI
Journal:  Can Med Assoc J       Date:  1964-11-07       Impact factor: 8.262

View more
  3 in total

1.  Effect of quinidine on plasma concentration and renal clearance of digoxin. A clinically important drug interaction.

Authors:  R Dahlqvist; G Ejvinsson; K Schenck-Gustafsson
Journal:  Br J Clin Pharmacol       Date:  1980-04       Impact factor: 4.335

Review 2.  Clinical pharmacokinetics of quinidine.

Authors:  H R Ochs; D J Greenblatt; E Woo
Journal:  Clin Pharmacokinet       Date:  1980 Mar-Apr       Impact factor: 6.447

3.  Pharmacokinetics of digoxin in patients subjected to the quinidine-digoxin interaction.

Authors:  K Schenck-Gustafsson; R Dahlqvist
Journal:  Br J Clin Pharmacol       Date:  1981-02       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.